← Back
Data updated: Mar 10, 2026
ACTELION
CardiovascularRespiratoryNeurology
ACTELION is a major pharmaceutical company focused on Cardiovascular, Respiratory, Neurology. Key products include OPSUMIT.
2001
Since
7
Drugs
-
Trials
15
Approved (2yr)
Key Drugs
Recent Activity
TRACLEER 2025-11-05
REMS
TRACLEER 2025-11-05
REMS
TRACLEER 2025-07-30
Labeling
TRACLEER 2025-07-30
Labeling
OPSUMIT 2025-04-02
REMS
OPSYNVI 2025-04-02
REMS
OPSUMIT 2025-02-28
Efficacy
TRACLEER 2025-02-21
REMS
TRACLEER 2025-02-21
REMS
OPSUMIT 2024-12-12
REMS
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 49%
5 drugs Phase 3: 15 Phase 2: 6 Phase 1: 8
Respiratory 45%
5 drugs Phase 3: 13 Phase 2: 5 Phase 1: 8
Neurology 5%
0 drugs Phase 3: 3
Infectious Disease 1%
0 drugs Phase 2: 1
Pipeline Strength Pro
Loading...
Competitors Pro
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Respiratory
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Neurology, Respiratory
GSK big-pharma
Infectious Disease, Respiratory, Neurology
APOTHECON specialty
Infectious Disease, Cardiovascular, Respiratory
Novo Nordisk big-pharma
Cardiovascular, Infectious Disease, Neurology